136 related articles for article (PubMed ID: 20524451)
1. Bilateral atypical femoral fractures after long-term alendronate therapy: a case report.
Bamrungsong T; Pongchaiyakul C
J Med Assoc Thai; 2010 May; 93(5):620-4. PubMed ID: 20524451
[TBL] [Abstract][Full Text] [Related]
2. Case reports: two femoral insufficiency fractures after long-term alendronate therapy.
Sayed-Noor AS; Sjödén GO
Clin Orthop Relat Res; 2009 Jul; 467(7):1921-6. PubMed ID: 19198962
[TBL] [Abstract][Full Text] [Related]
3. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy.
Capeci CM; Tejwani NC
J Bone Joint Surg Am; 2009 Nov; 91(11):2556-61. PubMed ID: 19884427
[TBL] [Abstract][Full Text] [Related]
4. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
Cross MB; Nam D; van der Meulen MC; Bostrom MP
J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959
[TBL] [Abstract][Full Text] [Related]
5. Bilateral low-energy sequential femoral shaft fractures in patients on long-term bisphosphonate therapy.
Çakmak S; Mahiroğulları M; Keklikçi K; Sarı E; Erdik B; Rodop O
Acta Orthop Traumatol Turc; 2013; 47(3):162-72. PubMed ID: 23748615
[TBL] [Abstract][Full Text] [Related]
6. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.
Goh SK; Yang KY; Koh JS; Wong MK; Chua SY; Chua DT; Howe TS
J Bone Joint Surg Br; 2007 Mar; 89(3):349-53. PubMed ID: 17356148
[TBL] [Abstract][Full Text] [Related]
7. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?
Kwek EB; Goh SK; Koh JS; Png MA; Howe TS
Injury; 2008 Feb; 39(2):224-31. PubMed ID: 18222447
[TBL] [Abstract][Full Text] [Related]
8. A rational approach to management of alendronate-related subtrochanteric fractures.
Das De S; Setiobudi T; Shen L; Das De S
J Bone Joint Surg Br; 2010 May; 92(5):679-86. PubMed ID: 20436006
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-associated atypical subtrochanteric femur fractures in the older patient.
Gopal GK; Tam KL; Krishnan SP; Maddern IL
N Z Med J; 2014 Feb; 127(1389):81-5. PubMed ID: 24548959
[TBL] [Abstract][Full Text] [Related]
10. Pseudoarthrosis in atypical femoral fracture: case report.
Giannotti S; Bottai V; Dell'Osso G; De Paola G; Ghilardi M; Guido G
Osteoporos Int; 2013 Nov; 24(11):2893-5. PubMed ID: 23681089
[TBL] [Abstract][Full Text] [Related]
11. Femoral fractures in osteoporotic patients on bisphosphonates. A case report.
Alshahrani F; Kendler D
J Clin Densitom; 2012; 15(3):380-4. PubMed ID: 22572530
[TBL] [Abstract][Full Text] [Related]
12. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
Chiu WY; Lee JJ; Tsai KS
J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975
[TBL] [Abstract][Full Text] [Related]
13. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.
Huang HT; Kang L; Huang PJ; Fu YC; Lin SY; Hsieh CH; Chen JC; Cheng YM; Chen CH
Menopause; 2012 Dec; 19(12):1360-3. PubMed ID: 22968250
[TBL] [Abstract][Full Text] [Related]
14. Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.
Lee JK
Int J Rheum Dis; 2009 Jul; 12(2):149-54. PubMed ID: 20374333
[TBL] [Abstract][Full Text] [Related]
15. Atypical femoral fractures bilaterally in a patient receiving denosumab.
Drampalos E; Skarpas G; Barbounakis N; Michos I
Acta Orthop; 2014 Feb; 85(1):3-5. PubMed ID: 24171686
[No Abstract] [Full Text] [Related]
16. Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.
Abrahamsen B; Eiken P; Eastell R
J Clin Endocrinol Metab; 2010 Dec; 95(12):5258-65. PubMed ID: 20843943
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous femoral shaft fracture after long-term alendronate.
Ali T; Jay RH
Age Ageing; 2009 Sep; 38(5):625-6. PubMed ID: 19556326
[TBL] [Abstract][Full Text] [Related]
18. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
Park KT; Lee KB
Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
[TBL] [Abstract][Full Text] [Related]
19. Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.
Ng YH; Gino PD; Lingaraj K; Das De S
Injury; 2011 Jul; 42(7):702-6. PubMed ID: 21316051
[TBL] [Abstract][Full Text] [Related]
20. [Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the risk].
Sjödén G; Sayed-Noor A; Kadum B; Pettersson U
Lakartidningen; 2010 Oct 13-19; 107(41):2482-3. PubMed ID: 21137565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
